Inovio Pharmaceuticals is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.
Inovio Pharmaceuticals is a publicly traded company on NMS using the ticker symbol INO.
Detailed information on company financials and operating reports can be found here:
NMS: INO
Inovio Pharmaceuticals Annual Revenue and Growth Rate
Note: Inovio Pharmaceuticals's revenues are gauged from an analysis of company filings.
Investor Activity
Inovio Pharmaceuticals has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
January 24, 2020
1
100%
$4 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Inovio Pharmaceuticals is developing and marketing.
Inovio Pharmaceuticals doesn't have any recent trademark applications, indicating Inovio Pharmaceuticals is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
IMMUNO-INGENUITY Pharmaceutical preparations for human use for the treatment and prevention of cancer and infectious diseases; pharmaceutical preparations for human use, namely, antibiotics, antifungals and anti-virals
11/09/2020
DBITE Pharmaceutical compositions; Nucleic acid sequences for medical purposes; Pharmaceutical preparations containing nucleic acid sequences that encode monoclonal antibodies or fragments thereof for immunotherapies for cancer
04/01/2019
GENEOS THERAPEUTICS Research and development in the fields of pharmaceuticals, biopharmaceuticals and therapeutics; Research and development in the field of personalized medicine and its delivery to patients; Research and development in the field of oncology; Research and development of personalized cancer treatments; Medical and scientific research, namely, conducting clinical trials for others; Research and development of treatments for infectious diseases
01/04/2017
See all trademarks and details in the Full Report.
Market Share of Inovio Pharmaceuticals's Largest Competitors
A competitive analysis shows these companies are in the same general field as Inovio Pharmaceuticals, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Inovio Pharmaceuticals.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Inovio Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.